Clinical Trial Update: Liraglutide Effects on Epicardial Fat Inflammatory Genes [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating liraglutide's impact on epicardial fat inflammatory gene expression in individuals with type 2 diabetes mellitus and coronary artery di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• liraglutide (liraglutide)

Snippet

Sponsor: University of Miami | Conditions: Type2 Diabetes, Coronary Artery Disease | Phase 4 | Status: COMPLETED | Results posted: 2025-07-08